General Information of the Compound
| Compound ID |
CP0900483
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5R*)-N5-(4-Bromophenyl)-(6R*)-N6-[(2-imidazolidin-2-on-1-yl)-ethyl]-(4S*,7R*)-[4,7-ethylene-spiro[2.4]heptane]-5,6-dicarboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H27BrN4O3
|
||||||||||||||||||
| Molecular Weight |
475.387
|
||||||||||||||||||
| Canonical SMILES |
O=C(NCCN1CCNC1=O)[C@H]1[C@H](C(=O)Nc2ccc(Br)cc2)[C@@H]2CC[C@H]1C21CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H27BrN4O3/c23-13-1-3-14(4-2-13)26-20(29)18-16-6-5-15(22(16)7-8-22)17(18)19(28)24-9-11-27-12-10-25-21(27)30/h1-4,15-18H,5-12H2,(H,24,28)(H,25,30)(H,26,29)/t15-,16+,17-,18-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
BFGWEZDDHDCMQF-XMTFNYHQSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00605, FML2_HUMAN
Protein ID: PT02590, N-formyl peptide receptor 2